Orthofix Medical (OFIX) Cash from Operations Growth (1y) (2011 - 2026)
Orthofix Medical (OFIX) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 185.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 122.43% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 16.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthofix Medical | 443.33 Mn | 322.46 Mn | 139.55 Mn | 4.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.25% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 6.26% |
| Jun 30, 2025 | 29.55% |
| Mar 31, 2025 | 1.10% |
| Dec 31, 2024 | 454.50% |
| Sep 30, 2024 | 2,346.75% |
| Jun 30, 2024 | 262.87% |
| Mar 31, 2024 | 45.34% |
| Dec 31, 2023 | -385.09% |
| Sep 30, 2023 | 137.74% |
| Jun 30, 2023 | -12.27% |
| Mar 31, 2023 | -341.30% |
| Dec 31, 2022 | -80.07% |
| Sep 30, 2022 | -119.65% |
| Jun 30, 2022 | -125.68% |
| Mar 31, 2022 | -415.81% |
| Dec 31, 2021 | -47.16% |
| Sep 30, 2021 | -70.61% |
| Jun 30, 2021 | -112.35% |